If Texas—one of America’s most conservative states and a major hemp producer—signals voter support for legalization, it could dramatically accelerate federal cannabis reform that affects your access to products. In one of the first double-blind, placebo-controlled clinical trials of isolated CBG in humans, a 20mg oral dose of hemp-derived cannabigerol produced statistically significant reductions in subjective anxiety and stress, along with improved verbal memory, without intoxication, cognitive slowing, or motor impairment. The study of 34 healthy adults suggests CBG may influence stress and anxiety pathways without producing typical ‘drug effects.’ Researchers emphasize preliminary nature and need for replication.
Patients Who Rely on Hemp-Derived CBD Face ‘Abrupt Disruptions in Care’
If you use hemp CBD because your state doesn’t have a medical cannabis program or because prescriptions are too expensive, you could lose access in November with no alternative in place. Americans for Safe Access warns that patients who turned to hemp-derived CBD due to cost, access deserts, and limited state medical programs may face sudden loss of access when the Nov ban hits. The FDA’s cannabinoid deadline doesn’t establish clinical pathways, insurance coverage, or patient safeguards.
10 Powerful Ways Cannabis Supports Children’s Behavior
Real-world stories of how cannabis brings calm, balance, and relief TL;DR Cannabis may offer relief for under-recognized behavioral challenges in children. Conditions like rage attacks, compulsive behaviors, and mood instability show early...